Somatic mutations altering Tyr641 of EZH2 are rare in primary central nervous system lymphoma

Leukemia and Lymphoma

Volumn 51, Issue 11, 2010, Pages 2135-2136

  Pellissery, Shoji ^a   Richter, Julia ^a   Haake, Andrea ^a   Montesinos Rongen, Manuel ^b   Deckert, Martina ^b   Siebert, Reiner ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR EZH2; TYROSINE;

GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; MUTATIONAL ANALYSIS; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; SOMATIC HYPERMUTATION; SOMATIC MUTATION;

BIOPSY; CELL LINE, TUMOR; CENTRAL NERVOUS SYSTEM NEOPLASMS; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; GENE FREQUENCY; HUMANS; LYMPHOMA; MUTATION, MISSENSE; TRANSCRIPTION FACTORS; TYROSINE;

EID: 78649233179     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2010.510897     Document Type: Letter

References (9)

1. Montesinos-Rongen M, Brunn A, Bentink S, et al. Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell. Leukemia 2008;22:400-405.
2. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-511.
3. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002;346:1937-1947.
4. Bea S, Zettl A, Wright G, et al. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. Blood 2005;106:3183-3190.
5. Martin-Subero JI, Ammerpohl O, Bibikova M, et al. A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms. PLoS One 2009;4:e6986.
6. Camilleri-Broet S, Criniere E, Broet P, et al. A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases. Blood 2006;107:190-196.
7. Schwindt H, Vater I, Kreuz M, et al. Chromosomal imbalances and partial uniparental disomies in primary central nervous system lymphoma. Leukemia 2009;23:1875-1884.
8. Morin RD, Johnson NA, Severson TM, et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet 2010;42:181-185.
9. Richter J, Ammerpohl O, Martin-Subero JI, et al. Array-based DNA methylation profiling of primary lymphomas of the central nervous system. BMC Cancer 2009;9:455.